Replidyne will present the following C. difficile posters on Thursday, September 20 at 10:00 AM, Room E253D:
-- Poster F1-2112, titled "Novel Inhibitors of Methionyl tRNA Synthestase
from Clostridium difficile: Identification and Synthesis of REP3123."
-- Poster F1-2113, titled "REP3123 is a Potent and Selective Inhibitor of
Methionyl tRNA Synthetase from Clostridium difficile."
-- Poster F1-2114, titled "Co-crystal Structure of REP3123 Bound to
Clostridium difficile Methionyl tRNA Synthetase."
-- Poster F1-2115, titled "Spectrum of Activity of REP3123 against
Aerobic Bacterial Pathogens."
-- Poster F1-2117, titled "In vitro Activity of REP3123 against
Clostridium difficile and Other Anaerobic Intestinal Bacteria."
-- Poster F1-2118, titled "REP3123: A Narrow Spectrum Antibacterial Agent
that Inhibits Growth and Prevents Sporulation in Clostridium
-- Poster F1-2119, titled "REP3123 Inhibits Toxin Production in C.
-- Poster F1-2120, titled "Efficacy of Novel MetRS Inhibitors in a C.
difficile Hamster Model."
Monday, September 17 at 12:00 PM, Hall D:
-- Poster E-256, titled "Comparison of the Bactericidal Activities of
Faropenem, Ertapenem, Amoxicillin, Cefixime, Cefuroxime and
Moxifloxacin against Streptococcus pneumoniae."
-- Poster E-257, titled "Comparative Ability of Faropenem to Select for
Resistant Mutants of S. pneumoniae."
-- Poster E-258, titled "Comparative Ability of Faropenem to Sele
|SOURCE Replidyne, Inc.|
Copyright©2007 PR Newswire.
All rights reserved